Wegovy pill, the first oral GLP-1 for weight loss, is FDA-approved for reducing cardiovascular risks in adults. Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.

Inflation in November fell to 2.7%, the Bureau of Labor Statistics said Thursday, a positive sign for consumers on its face. However, November’s data was collected later than normal. The released ...

- ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 ...

What do Orajel products treat? Orajel products are used to treat mouth pain, including cold sores (fever blisters) and canker sores. Cold sores are caused by a virus called herpes simplex virus (HSV), ...

The Ozempic, Wegovy maker said oral semaglutide, which is the key ingredient in its diabetes and weight-loss drugs, didn't work better than placebo against Alzheimer's Novo Nordisk's stock tumbles ...

Orforglipron (LY3502970) is a small-molecule, non-peptide GLP-1RA designed for oral use. Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption ...

Please provide your email address to receive an email when new articles are posted on . An oral PCSK9 inhibitor lowered LDL cholesterol by up to 60% and improved other lipid parameters at 24 weeks.

There are only a few credit cards that are truly great for everyone: Big spenders, penny-pinchers, and everybody in between. The Wells Fargo Active Cash® Card (rates and fees) is one of them. That's ...

Millions of people with obesity avoid treatment because current GLP-1 drugs are only available as injections. Results from a Phase 3 trial show that a daily oral pill version of semaglutide from Novo ...